124 related articles for article (PubMed ID: 2329557)
1. Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1990 May; 33(5):1375-9. PubMed ID: 2329557
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo.
Rewcastle GW; Atwell GJ; Baguley BC; Calveley SB; Denny WA
J Med Chem; 1989 Apr; 32(4):793-9. PubMed ID: 2704025
[TBL] [Abstract][Full Text] [Related]
3. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids.
Rewcastle GW; Atwell GJ; Li ZA; Baguley BC; Denny WA
J Med Chem; 1991 Jan; 34(1):217-22. PubMed ID: 1992120
[TBL] [Abstract][Full Text] [Related]
4. Potential antitumor agents. 62. Structure-activity relationships for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acid.
Rewcastle GW; Atwell GJ; Palmer BD; Boyd PD; Baguley BC; Denny WA
J Med Chem; 1991 Feb; 34(2):491-6. PubMed ID: 1995870
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships for substituted 9-oxo-9,10-dihydroacridine-4-acetic acids: analogues of the colon tumour active agent xanthenone-4-acetic acid.
Gamage SA; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1992 Oct; 7(5):403-14. PubMed ID: 1388631
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-tumour activity of topologically-related analogues of flavoneacetic acid.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
Anticancer Drug Des; 1989 Aug; 4(2):161-9. PubMed ID: 2803464
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.
Gobbi S; Rampa A; Bisi A; Belluti F; Valenti P; Caputo A; Zampiron A; Carrara M
J Med Chem; 2002 Oct; 45(22):4931-9. PubMed ID: 12383019
[TBL] [Abstract][Full Text] [Related]
8. Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.
Futami H; Eader L; Back TT; Gruys E; Young HA; Wiltrout RH; Baguley BC
J Immunother (1991); 1992 Nov; 12(4):247-55. PubMed ID: 1477076
[TBL] [Abstract][Full Text] [Related]
9. Potential antitumor agents. 63. Structure-activity relationships for side-chain analogues of the colon 38 active agent 9-oxo-9H-xanthene-4-acetic acid.
Rewcastle GW; Atwell GJ; Baguley BC; Boyd M; Thomsen LL; Zhuang L; Denny WA
J Med Chem; 1991 Sep; 34(9):2864-70. PubMed ID: 1895304
[TBL] [Abstract][Full Text] [Related]
10. Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.
Veszelovszky E; Thomsen LL; Li Z; Baguley BC
Eur J Cancer; 1993; 29A(3):404-8. PubMed ID: 8398341
[TBL] [Abstract][Full Text] [Related]
11. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
[TBL] [Abstract][Full Text] [Related]
12. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
Zwi LJ; Baguley BC; Gavin JB; Wilson WR
Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
Denny WA; Atwell GJ; Rewcastle GW; Baguley BC
J Med Chem; 1987 Apr; 30(4):658-63. PubMed ID: 3560160
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of some analogues of flavone acetic acid.
Valenti P; Fabbri G; Rampa A; Bisi A; Gobbi S; Da Re P; Carrara M; Sgevano A; Cima L
Anticancer Drug Des; 1996 Apr; 11(3):243-52. PubMed ID: 8663911
[TBL] [Abstract][Full Text] [Related]
17. Modulation of superoxide production from murine macrophages by the antitumour agent flavone acetic acid and xanthenone acetic acid analogues.
Thomsen LL; Baguley BC; Ching LM; Gavin JB
Biochem Pharmacol; 1992 Jan; 43(2):386-9. PubMed ID: 1310856
[No Abstract] [Full Text] [Related]
18. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 7. Bisalkamine esters of 9-oxoxanthene-2,7-dicarboxylic acid, 3,6-bis-basic ethers of xanthen-9-one, and 2,7-bis(aminoacyl)xanthen-9-ones-xanthenes, and -thioxanthenes.
Carr AA; Grunwell JF; Sill AD; Meyer DR; Sweet FW; Scheve BJ; Grisar JM; Fleming RW; Mayer GD
J Med Chem; 1976 Sep; 19(9):1142-8. PubMed ID: 185385
[TBL] [Abstract][Full Text] [Related]
19. Preparation and antitumor activities of some derivatives of 5-methoxysterigmatocystin.
Essery JM; O'Herron FA; McGregor DN; Bradner WT
J Med Chem; 1976 Nov; 19(11):1339-42. PubMed ID: 1003414
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of structural analogues of the epipodophyllotoxins.
Klein LL; Yeung CM; Chu DT; McDonald EJ; Clement JJ; Plattner JJ
J Med Chem; 1991 Mar; 34(3):984-92. PubMed ID: 2002477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
